Strategy and Innovation Leading the PBM Industry
At Prime, our success is determined by our ability to assess the critical role that PBMs play in today's dynamically changing health care landscape; and to respond, with strategy and purpose, to the shifting needs of our clients, employer groups and members.
Follow us in the media and read about the important issues facing us today and what we're doing to address them.
Recent News
Prime Therapeutics President and CEO Eric Elliott cites urgent need for "true integration" of PBMs, plans at 2012 PCMA Managed Markets Educational Forum (February 8, 2012)
Prime Therapeutics Plans Minnesota Expansion (December 20, 2011)
BCBSNC Invests in Pharmacy Benefits Manager Prime Therapeutics (December 1, 2011)
Prime Therapeutics launches retail medication therapy management program (November 15, 2011)
Study Finds New Blood Thinning Medication, Pradaxa®, Comes at High Cost (October 20, 2011)
Study Finds Children More Likely to Receive Recommended RSV Medication Doses When Administered Through Specialty Pharmacy (October 20, 2011)
Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs (October 10, 2011)
Prime Therapeutics Launches CareCentered Contracting™ Program (September 22, 2011)
Prime Therapeutics Launches Development of GuidedHealth℠ Clinical Platform (September 15, 2011)
Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry (August 24, 2011)
Prime Therapeutics Announces Pharmacy Offering with Guaranteed Net Spend Per Prescription (August 11, 2011)
BCBSNC Could Change Pharmacy Benefits Management Vendor to Prime Therapeutics (August 3, 2011)
Michael Showalter Joins Prime Therapeutics as Chief Marketing Officer (July 21, 2011)
Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement (June 15, 2011)
For Patients on Statins, Study Finds Filling 90 Day Supply Prescriptions through Mail Service Compared to Retail Pharmacy is Associated with Less Waste (April 27, 2011)
New Study Finds Individuals who Adhere to Their Diabetes Medication have a 31% Associated Lower Risk of Hospitalization (April 27, 2011)
Study Finds Letter to Health Care Providers Results in Reduction of Potentially Unsafe Concurrent Use of Plavix and Proton Pump Inhibitors (April 18, 2011)
Study Finds Multiple Sclerosis Pharmacy Costs Increasing Faster than Medical Costs (April 14, 2011)
Point-of-Sale Electronic Safety Check May Reduce Heart Attack Risk for Diabetic Patients (April 12, 2011)
Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference (February 16, 2011)
Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum (February 8, 2011)
Media Release Archive
Access our archive of media releases.
Media Contact
Contact us for more information or with any media queries.
AMCP Posters
Impact of a Rosiglitazone (Avandia®) Electronic Safety Edit: Cohort Study
Diabetes Medication Adherence Association with Hospitalizations and Total Cost of Care
Multiple Sclerosis Medical and Pharmacy Cost Trends 2006 to 2009
Low Montelukast (Singulair®) Persistence Regardless of Diagnosis: Utilization Management Opportunity
Statin Waste Associated with 90-day Supplies Compared to 30-day Supplies
Prime At-a-Glance
Download our corporate snapshot.
Industry Insights
Building Comparative Effectiveness Research into Health Care Reform